Eleven specialized portfolios spanning the full life sciences value chain — connecting scientists, clinicians, regulators, and commercial leaders across pharma, biotech, medical devices, and healthcare.
Market access, channel strategy, and patient-access leaders shaping commercialization.
Discovery, engineering, and development of next-generation antibody therapeutics.
The global community advancing biopharmaceutical development and manufacturing.
Research, manufacturing, and commercialization of advanced cell and gene therapies.
Clinical operations, trial innovation, and patient-centric study design.
Regulatory strategy, compliance, and legal leadership across life sciences.








CFOs, controllers, and finance leaders across pharma, biotech, and medtech.
Medical affairs, congresses, and scientific communications planning.
Oligonucleotides, peptides, and RNA therapeutics — discovery through manufacturing.
BD, licensing, and investor communities driving life sciences dealmaking.
Pricing strategy, contracting, and reimbursement across payer ecosystems.
Sponsorship, thought-leadership, and integrated campaigns across the full Informa Life Sciences portfolio.